Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion type Assertion NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_head.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion description "[The Gly16 mutation of the beta2-adrenoceptor gene is associated with increased insulin resistance, adiposity, and BP accompanied by higher plasma NE levels early in the metabolic disease in developing obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_provenance.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion evidence source_evidence_literature NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_provenance.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion SIO_000772 16054001 NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_provenance.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion wasDerivedFrom befree-20140225 NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_provenance.
- NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_assertion wasGeneratedBy ECO_0000203 NP405891.RAFAXENB-1SdRxblJk6niKp9o2lTR6mxB918MYPkwq3d8130_provenance.